Following Push by Malliotakis, NYS Therapeutic Allocations Increase, Malliotakis Calls for Full Transparency

(STATEN ISLAND, NY) - Following her December 23, 2021, letter to President Biden urging the Administration to increase the supply and distribution of COVID-19 therapeutic treatments, Congresswoman Nicole Malliotakis (NY-11) is pleased to see New York State's weekly allocation of monoclonal antibody doses double.

For the two-week period spanning December 13-December 26, 2021, New York State received only 18,516 units of monoclonal antibody treatments out of the 255,002 units that were distributed nationally. Following Malliotakis' letter to President Biden, New York State has received 43,198 doses since December 27, 2021, more than twice the amount it was receiving on a weekly basis previously. 

"I'm pleased to see the federal government increase New York State's weekly allocation of monoclonal antibodies by thousands of units, providing us with the most units nationwide for two weeks in a row," Malliotakis said. "We are now two years and multiple variants into this pandemic. It is clear that COVID 19 is going to remain among us in one form or another, I continue to urge the administration to expand its arsenal against COVID-19 by upping the supply and distribution of therapeutic treatments that could both save lives and get us back to normalcy."

Malliotakis also slammed New York State's new guidelines that access to treatments will be prioritized by race, and called on New York Governor Kathy Hochul to be fully transparent about where exactly COVID-19 therapeutic treatments are being distributed to ensure equitable distribution across all facilities that have patients in need.

Malliotakis added: "Now that our state is receiving an increased allocation, I urge Governor Hochul to be fully transparent with the public as to how these therapeutic treatments are being distributed to hospitals and medical facilities across New York State by providing a full accounting of the number of units each facility requested and how many were actually received. I was deeply disturbed to see New York City and State change guidelines to a race-based approach when deciding how to distribute and whom to administer these life-saving treatments. This policy is simply wrong and should be reversed so an individual's medical condition is a priority regardless of race."